To study the effects of IGF2R blockade on muscular dystrophy, we intravenously administered anti‐IGF2R antibodies at low (10 μg per mouse) and high (100 μg per mouse) dosages to 3‐month‐old mdx mice for 4 and 9 weeks. This evidence concerns the gene IGF2R and muscular dystrophy.